Most importantly, the introduction of Indian government's ‘test-and-treat’ policy, irrespective of the CD4 counts and clinical stage of the disease, catalyzed the process of “Treatment as Prevention” (TasP)11 Moreover, the rate of new infections and deaths is not falling rapidly enough in meeting the 90–90–90 ambitious treatment target to help end the AIDS epidemic given by the Joint United Nations Programme on HIV/AIDS (UNAIDS).16 The gene discussed is CD4; the disease is infection.